How much Copper is recommended in the AREDS2 supplementation regimen?

The AREDS2 (Age-Related Eye Disease Study 2) formulation emphasizes the importance of a balanced combination of nutrients to support eye health in patients at risk for advanced age-related macular degeneration (AMD). The recommendation for copper is to include 2 mg in the supplementation regimen.

Copper plays a crucial role in various enzymatic processes in the body, including those that are involved in the maintenance of vision and the overall health of the retina. In the context of AMD, adequate copper levels are important because they contribute to the prevention of oxidative damage in retinal tissues. The specific dosage aligns with the aim to prevent copper deficiency without significantly increasing the risk of adverse effects, as higher amounts may have negative implications for health.

Other options present either too low or too high a dose of copper, which may not provide the necessary benefits for eye health or could pose potential risks. The chosen amount of 2 mg is established based on thorough research and clinical trials, ensuring a balance that supports patients' needs during AMD management.